Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,815 | 842 | 98.4% |
| Education | $190.36 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,736 | 142 | $0 (2024) |
| ABBVIE INC. | $1,426 | 89 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,199 | 104 | $0 (2024) |
| PFIZER INC. | $1,026 | 86 | $0 (2024) |
| Lilly USA, LLC | $813.47 | 63 | $0 (2024) |
| Astellas Pharma US Inc | $696.79 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $584.63 | 48 | $0 (2024) |
| Amgen Inc. | $529.25 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $523.85 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $454.02 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,970 | 131 | ABBVIE INC. ($328.64) |
| 2023 | $1,789 | 123 | AbbVie Inc. ($388.79) |
| 2022 | $2,063 | 122 | ABBVIE INC. ($243.58) |
| 2021 | $1,821 | 110 | AbbVie Inc. ($422.75) |
| 2020 | $823.51 | 64 | GlaxoSmithKline, LLC. ($184.38) |
| 2019 | $1,229 | 101 | Novo Nordisk Inc ($222.65) |
| 2018 | $1,246 | 102 | Novo Nordisk Inc ($342.15) |
| 2017 | $1,064 | 93 | Novo Nordisk Inc ($177.41) |
All Payment Transactions
846 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Obesity | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Biological | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 665 | 995 | $138,287 | $72,126 |
| 2022 | 13 | 643 | 917 | $119,874 | $57,711 |
| 2021 | 13 | 548 | 785 | $100,605 | $45,791 |
| 2020 | 12 | 529 | 741 | $83,963 | $27,402 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 341 | $60,357 | $27,841 | 46.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $18,750 | $14,135 | 75.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $30,284 | $13,845 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 124 | $14,880 | $7,418 | 49.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 56 | 57 | $4,560 | $4,321 | 94.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 57 | $3,876 | $1,674 | 43.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 49 | 49 | $3,332 | $1,439 | 43.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 89 | 152 | $1,520 | $1,277 | 84.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 34 | 52 | $728.00 | $177.32 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 337 | $59,649 | $28,055 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $29,748 | $13,940 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 96 | $11,520 | $5,911 | 51.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 46 | $3,680 | $3,146 | 85.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $4,940 | $2,105 | 42.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $2,080 | $1,711 | 82.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $3,128 | $1,287 | 41.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,632 | $675.61 | 41.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 88 | 134 | $1,340 | $397.47 | 29.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 25 | 27 | $540.00 | $166.77 | 30.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 25 | 27 | $567.00 | $138.66 | 24.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 26 | 29 | $406.00 | $100.01 | 24.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 14 | 14 | $644.00 | $77.14 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 284 | $50,268 | $21,986 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 103 | 103 | $27,604 | $13,252 | 48.0% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $3,630 | $2,655 | 73.1% |
About Dr. Andrea Cerone, M.D
Dr. Andrea Cerone, M.D is a Family Medicine healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881684629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Cerone, M.D has received a total of $12,005 in payments from pharmaceutical and medical device companies, with $1,970 received in 2024. These payments were reported across 846 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($11,815).
As a Medicare-enrolled provider, Cerone has provided services to 2,385 Medicare beneficiaries, totaling 3,438 services with total Medicare billing of $203,029. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cuyahoga Falls, OH
- Active Since 10/24/2005
- Last Updated 09/01/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881684629
Products in Payments
- UBRELVY (Drug) $608.19
- Ozempic (Drug) $516.47
- TRELEGY ELLIPTA (Drug) $491.98
- VRAYLAR (Drug) $481.05
- JARDIANCE (Drug) $442.45
- MOUNJARO (Drug) $406.82
- NURTEC ODT (Drug) $403.25
- Kerendia (Drug) $315.78
- FARXIGA (Drug) $310.93
- Victoza (Drug) $305.47
- Rybelsus (Drug) $297.71
- XIFAXAN (Drug) $268.12
- Aimovig (Biological) $257.09
- QULIPTA (Drug) $251.65
- JANUVIA (Drug) $242.42
- Saxenda (Drug) $210.39
- PREVNAR 20 (Biological) $200.02
- Myrbetriq (Drug) $191.22
- ELIQUIS (Drug) $178.06
- ANORO (Drug) $172.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cuyahoga Falls
Dr. Tricia Bedrick, D.o, D.O
Family Medicine — Payments: $223,294
Muhamad Musa, M.d, M.D
Family Medicine — Payments: $19,605
Dr. Scott Higley, D.o, D.O
Family Medicine — Payments: $16,424
William Schukay, Do, DO
Family Medicine — Payments: $16,108
James Johnston, D.o, D.O
Family Medicine — Payments: $15,241
Victoria Digennaro, D.o, D.O
Family Medicine — Payments: $13,874